TECENTRIQ
TECENTRIQ
Approved
DIN Number
02492393
Drug Class
Human
Market Date
Oct 16, 2019
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02492393
AIG Number0158930001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FF05 ATEZOLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ATEZOLIZUMABActive
Strength: 840 MG / 14 ML
Monograph: ATEZOLIZUMAB